What is 32Co?
Founded in 2021 and headquartered in London, 32Co operates at the intersection of telemedicine and clinical collaboration. The company provides a sophisticated platform that enables general practitioners to consult with a global network of specialists, effectively democratizing access to expert medical insights. By integrating specialist knowledge into the primary care workflow, 32Co addresses critical inefficiencies in the healthcare delivery system. The firm's business model is designed to scale expertise beyond traditional clinic boundaries, positioning it as a pivotal player in the digital health transformation. Its core value proposition lies in enhancing patient outcomes while maintaining the convenience of local clinical interactions, a strategy that has garnered significant attention from institutional investors focused on healthcare innovation.
How much funding has 32Co raised?
32Co has raised a total of $2.7M across 1 funding round:
Other Financing Round
$2.7M
Other Financing Round (2023): $2.7M with participation from Balderton and Wavemaker Three-Sixty Health
Key Investors in 32Co
Balderton
Balderton Capital is a London-based venture capital firm that raises dedicated funds to invest in early-stage, high-growth technology companies across Europe, typically leading Seed and Series A rounds.
Wavemaker Three-Sixty Health
Wavemaker Three-Sixty Health is a leading U.S. venture capital fund that focuses exclusively on early-stage healthcare startups, aiming to improve patient experiences and lower costs through disruptive innovation.
What's next for 32Co?
Looking ahead, 32Co is poised to leverage its recent capital to scale its collaborative network and enhance its proprietary technology stack. The company's strategic roadmap likely involves deepening its penetration into European markets while exploring potential cross-border clinical partnerships. As the healthcare sector continues to prioritize integrated care models, 32Co's ability to facilitate seamless communication between generalists and specialists will be a key driver of its long-term growth. Future initiatives will likely focus on optimizing the platform's user experience for clinicians and expanding the breadth of medical specialties available on the network. By maintaining its focus on high-quality clinical outcomes and operational efficiency, 32Co is well-positioned to navigate the complexities of the evolving digital health ecosystem.
See full 32Co company page
